BRIEF-Arch Biopartners says European Commission designated AB569 as orphan medicinal product in EU

Wed Jun 1, 2016 3:31pm EDT
 
Email This Article |
Share This Article
  • Facebook
  • LinkedIn
  • Twitter
| Print This Article
[-] Text [+]

June 1 (Reuters) - Arch Biopartners Inc :

* European Commission designated AB569 as orphan medicinal product in European Union for treatment of patients with cystic fibrosis Source text for Eikon: Further company coverage: